Back
ESC Premium Access

VEGF-B cardiac gene therapy with differential expression using the anf-promoter or therapy delay during heart failure development in a pre-clinical model of dilated cardiomyopathy.

Session: Poster session 7 - Genetics and gene therapy
Topic: Genetics and gene therapy
Speaker: Doctor F. Woitek (Leipzig, DE)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Felix Woitek

Heart Center of Leipzig, Leipzig (Germany)
0 follower

5 more presentations in this session

MicroRNA profiles in patients with cardiac amyloidosis and dilated cardiomyopathy - A preliminary epigenetic approach

Speaker: Doctor S. Becker (Stuttgart, DE)

Access
Abstract
Slides
Like
Thumbnail

GENomE wide analysis of Sotalol-induced IKr inhibition : lack of common variants with large effect sizes.

Speaker: Professor J. Hulot (Paris, FR)

Access
Abstract
Like
Thumbnail

BACE1-AS long noncoding RNA and beta-amyloid involvement in ischemic heart failure patients

Speaker: Doctor S. Greco (San Donato Milanese, IT)

Access
Abstract
Like
Thumbnail

MicroRNA 18a is a novel regulator of reverse cholesterol transport and potential therapeutic targets in atherosclerosis

Speaker: Assistant Professor T. Kim (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Brown adipose tissue dysfunction has a pathological role for the progression of cardiac metabolic remodeling in heart failure

Speaker: Doctor Y. Yoshida (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 7 - Genetics and gene therapy

Speakers: Doctor F. Woitek, Doctor S. Becker, Professor J. Hulot, Doctor S. Greco, Assistant Professor T. Kim...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources